fbpx
Medical Innovation Exchange

RegenXBio gets FDA support for Hunter syndrome gene therapy's accelerated review filing—in 2024

https://www.fiercebiotech.com/biotech/regenxbio-gets-fda-support-hunter-syndrome-gene-therapys-accelerated-review-filing-2024

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.